News about Consultants

TB Alliance and Lupin partner to manufacture anti-TB drug pretomanid

TB Alliance and Lupin partner to manufacture anti-TB drug pretomanid

The TB Alliance has granted Lupin a non-exclusive license to manufacture the anti-TB drug pretomanid as part of the three-drug ?BPaL? regimen. Lupin intends to commercialise the anti-tuberculosis (TB) medicine in approximately 140 countries and territories

Consultants | 07/09/2021 | By Darshana

Centrient Pharmaceuticals completes acquisition of Astral SteriTech

Centrient Pharmaceuticals completes acquisition of Astral SteriTech

With the addition of Astral SteriTech?s semi-synthetic cephalosporin and semi-synthetic penicillin sterile injectable finished dosage forms to Centrient?s product portfolio, the company can now further meet the needs of customers and reach more patients with its critical life-saving medicine

Consultants | 03/09/2021 | By Darshana

Novartis secures approval in China for Cosentyx

Novartis secures approval in China for Cosentyx

Novartis has announced that the China National Medical Products Administration (NMPA) has further approved Cosentyx for the treatment of moderate-to-severe plaque psoriasis in paediatric patients

Consultants | 19/08/2021 | By Darshana

Test At Home completes clinical trial on 'Lollipop-like' device that uses saliva for Covid-19 testing

Test At Home completes clinical trial on 'Lollipop-like' device that uses saliva for Covid-19 testing

Test At Home (TAH), backed by global VC firm Antler, is a medical technology startup, has completed clinical trial on its proprietary 'Lollipop-like' device that enables individuals to self-collect saliva sample for Covid-19 testing with around 95% accuracy based on initial clinical data

Consultants | 17/08/2021 | By Darshana

Mr. K.B.S. Anand and Dr. Punita Kumar-Sinha Join Lupin Board as Independent Directors

Mr. K.B.S. Anand and Dr. Punita Kumar-Sinha Join Lupin Board as Independent Directors

Pharma major Lupin Limited (Lupin) announced today the appointment of Mr. K.B.S. Anand and Dr. Punita Kumar-Sinha as Independent Directors.

Consultants | 13/08/2020 | By Darshana 179

VJ Farma seeks DCGI?s nod to import 5,000 remdesivir vials from Bangladesh for COVID-19 patients in Maharashtra

VJ Farma seeks DCGI?s nod to import 5,000 remdesivir vials from Bangladesh for COVID-19 patients in Maharashtra

Even as the number of COVID-19 cases in Maharashtra is increasing with each passing day and urgently needs remdesivir injections for critically ill patients, the Mumbai-based VJ Farma has sought no objection certificate (NOC) from Drugs Controller General of India (DCGI) for importing 5,000 remdesivir vials from a Bangladesh firm Eskayef Pharmaceuticals

Consultants | 09/07/2020 | By Darshana 173

Thyrocare launches coronavirus antibody tests across India, to conduct over 1,500 tests daily

Thyrocare launches coronavirus antibody tests across India, to conduct over 1,500 tests daily

Thyrocare, India?s leading diagnostic laboratory chain, has announced the availability of ?COVID Antibody Test? to check your body?s response to COVID-19 infection. It is not a diagnostic test, but is used for sero-surveillance to understand whether a person has encountered the infection in the recent past

Consultants | 05/07/2020 | By Darshana 182

FDA Announces First of Its Kind Pilot Program to Communicate Patient Reported Outcomes from Cancer Clinical Trials

FDA Announces First of Its Kind Pilot Program to Communicate Patient Reported Outcomes from Cancer Clinical Trials

The U.S. Food and Drug Administration today launched Project Patient Voice, an initiative of the FDA?s Oncology Center of Excellence (OCE). Through a new website, Project Patient Voice creates a consistent source of publicly available information describing patient-reported symptoms from cancer trials

Consultants | 24/06/2020 | By Darshana 174

FDA Approves Drug to Treat Infants and Children with HIV

FDA Approves Drug to Treat Infants and Children with HIV

Today, the U.S. Food and Drug Administration approved Tivicay (dolutegravir) tablets and Tivicay PD (dolutegravir) tablets for suspension to treat HIV-1 infection in pediatric patients at least four weeks old and weighing at least 3 kg (6.61 pounds) in combination with other antiretroviral treatments

Consultants | 15/06/2020 | By Darshana 147

Coronavirus: WHO stops trial of hydroxycloroquine due to safety concerns

Coronavirus: WHO stops trial of hydroxycloroquine due to safety concerns

The World Health Organization has suspended testing the malaria drug hydroxychloroquine in COVID-19 patients due to safety concerns, WHO Director General Tedros Adhanom Ghebreyesus said on Monday

Consultants | 26/05/2020 | By Darshana 173

 
 

 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology